These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37014920)

  • 1. Conditional permeabilization of the P. falciparum plasma membrane in infected cells links cation influx to reduced membrane integrity.
    Sylla M; Gupta A; Shao J; Desai SA
    PLoS One; 2023; 18(4):e0283776. PubMed ID: 37014920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarials Targeting the Malaria Parasite Cation ATPase
    Zagórska A; Jaromin A
    Curr Top Med Chem; 2023; 23(3):214-226. PubMed ID: 36411573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials.
    Spillman NJ; Allen RJ; McNamara CW; Yeung BK; Winzeler EA; Diagana TT; Kirk K
    Cell Host Microbe; 2013 Feb; 13(2):227-37. PubMed ID: 23414762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization and chemical inhibition of PfATP4-associated Na
    Rosling JEO; Ridgway MC; Summers RL; Kirk K; Lehane AM
    J Biol Chem; 2018 Aug; 293(34):13327-13337. PubMed ID: 29986883
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Barnes CBG; Dans MG; Jonsdottir TK; Crabb BS; Gilson PR
    Front Cell Infect Microbiol; 2022; 12():1060202. PubMed ID: 36530423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs.
    Spillman NJ; Kirk K
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):149-62. PubMed ID: 26401486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4.
    Gilson PR; Kumarasingha R; Thompson J; Zhang X; Penington JS; Kalhor R; Bullen HE; Lehane AM; Dans MG; de Koning-Ward TF; Holien JK; Soares da Costa TP; Hulett MD; Buskes MJ; Crabb BS; Kirk K; Papenfuss AT; Cowman AF; Abbott BM
    Sci Rep; 2019 Jul; 9(1):10292. PubMed ID: 31311978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ion Regulation in the Malaria Parasite.
    Kirk K
    Annu Rev Microbiol; 2015; 69():341-59. PubMed ID: 26488277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse Chemical Compounds Target Plasmodium falciparum Plasma Membrane Lipid Homeostasis.
    Bhatnagar S; Nicklas S; Morrisey JM; Goldberg DE; Vaidya AB
    ACS Infect Dis; 2019 Apr; 5(4):550-558. PubMed ID: 30638365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A G358S mutation in the Plasmodium falciparum Na
    Qiu D; Pei JV; Rosling JEO; Thathy V; Li D; Xue Y; Tanner JD; Penington JS; Aw YTV; Aw JYH; Xu G; Tripathi AK; Gnadig NF; Yeo T; Fairhurst KJ; Stokes BH; Murithi JM; Kümpornsin K; Hasemer H; Dennis ASM; Ridgway MC; Schmitt EK; Straimer J; Papenfuss AT; Lee MCS; Corry B; Sinnis P; Fidock DA; van Dooren GG; Kirk K; Lehane AM
    Nat Commun; 2022 Sep; 13(1):5746. PubMed ID: 36180431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4.
    Ashton TD; Dans MG; Favuzza P; Ngo A; Lehane AM; Zhang X; Qiu D; Chandra Maity B; De N; Schindler KA; Yeo T; Park H; Uhlemann AC; Churchyard A; Baum J; Fidock DA; Jarman KE; Lowes KN; Baud D; Brand S; Jackson PF; Cowman AF; Sleebs BE
    J Med Chem; 2023 Mar; 66(5):3540-3565. PubMed ID: 36812492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse chemotypes disrupt ion homeostasis in the Malaria parasite.
    Lehane AM; Ridgway MC; Baker E; Kirk K
    Mol Microbiol; 2014 Oct; 94(2):327-39. PubMed ID: 25145582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion metabolism in malaria-infected erythrocytes.
    Tanabe K
    Blood Cells; 1990; 16(2-3):437-49. PubMed ID: 2175223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic responses in blood-stage malaria parasites associated with increased and decreased sensitivity to PfATP4 inhibitors.
    Tewari SG; Elahi R; Kwan B; Rajaram K; Bhatnagar S; Reifman J; Prigge ST; Vaidya AB; Wallqvist A
    Malar J; 2023 Feb; 22(1):56. PubMed ID: 36788578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Ca
    Kushwaha AK; Apolis L; Ito D; Desai SA
    Cell Microbiol; 2018 Sep; 20(9):e12853. PubMed ID: 29726084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse antimalarials from whole-cell phenotypic screens disrupt malaria parasite ion and volume homeostasis.
    Dennis ASM; Rosling JEO; Lehane AM; Kirk K
    Sci Rep; 2018 Jun; 8(1):8795. PubMed ID: 29892073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ion channels of Plasmodium falciparum-infected human erythrocytes for antimalarial development.
    Desai SA
    Curr Drug Targets Infect Disord; 2004 Mar; 4(1):79-86. PubMed ID: 15032636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Swelling Induced by the Antimalarial KAE609 (Cipargamin) and Other PfATP4-Associated Antimalarials.
    Dennis ASM; Lehane AM; Ridgway MC; Holleran JP; Kirk K
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLAG3 Self-Associates in Malaria Parasites and Quantitatively Determines Nutrient Uptake Channels at the Host Membrane.
    Gupta A; Balabaskaran-Nina P; Nguitragool W; Saggu GS; Schureck MA; Desai SA
    mBio; 2018 May; 9(3):. PubMed ID: 29739907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Antimalarial Compounds That Require CLAG3 for Their Uptake by
    Mira-Martínez S; Pickford AK; Rovira-Graells N; Guetens P; Tintó-Font E; Cortés A; Rosanas-Urgell A
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.